Kimberly A. Foster

发表

Enabling Discovery Through Leveraging and Miniaturizing Pharmaceutical Principles and Processes

Roy Haskell, Kimberly A. Foster, Ching Kim Tye, 2015 .

The Organic Lab: A Status Quo Report and a Two-Semesters-in-One Approach

Kimberly A. Foster, Anne E. Moody, 1997 .

Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.

Kimberly A. Foster, M. Hussain, Chengyu Liu, 2018, Journal of pharmaceutical sciences.

Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical setting.

Kimberly A. Foster, D. Thompson, J. S. Daniels, 2010, Journal of pharmaceutical sciences.

Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration

Kimberly A. Foster, C. Gesenberg, K. Stefanski, 2021, Pharmaceutical Research.

Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode.

David S. Nirschl, Kimberly A. Foster, David S Nirschl, 2017, Journal of medicinal chemistry.

Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1.

Kimberly A. Foster, J. Fargnoli, J. Hunt, 2021, ACS medicinal chemistry letters.

Enhanced aqueous dissolution of hydrophobic apixaban via direct incorporation of hydrophilic nanographene oxide.

Kimberly A. Foster, S. Mitra, K. Stefanski, 2022, Colloids and surfaces. B, Biointerfaces.

Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders.

Kimberly A. Foster, C. Chu, A. Mathur, 2021, Journal of medicinal chemistry.

Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry.

Jung Min Park, Kimberly A. Foster, J. Park, 2002, International journal of pharmaceutics.

Application of ultrasound‐guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeys

Kimberly A. Foster, E. Janovitz, J. Smalley, 2019, Pharmacology research & perspectives.

Medium Throughput pK a Determinations of Drugs and Chemicals by Reverse Phase HPLC with an Organic Gradient

Kimberly A. Foster, Po‐Chang Chiang, Ching‐Chiang Su, 2006 .

Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities.

Kimberly A. Foster, Michael A. Galella, J. Barrish, 2023, Bioorganic & medicinal chemistry.

Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT2C Receptor Agonists.

Kimberly A. Foster, A. Azzará, J. Robl, 2017, Journal of medicinal chemistry.

Discovery of Novel Pyridinones as MGAT2 Inhibitors for the Treatment of Metabolic Disorders.

Kimberly A. Foster, C. Chu, A. Mathur, 2023, Bioorganic & Medicinal Chemistry Letters.

Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate

Kimberly A. Foster, S. Mitra, K. Stefanski, 2021, Molecules.

Utility of in situ sodium alginate/karaya gum gels to facilitate gastric retention in rodents.

Kimberly A. Foster, M. Morgen, M. Hageman, 2012, International journal of pharmaceutics.

Utility of gastric-retained alginate gels to modulate pharmacokinetic profiles in rats.

Kimberly A. Foster, M. Hageman, Huadong Sun, 2013, Journal of pharmaceutical sciences.

Discovery of 12 (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders.

Lidet K. Negash, Kimberly A. Foster, A. Mathur, 2023, Journal of medicinal chemistry.

Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical setting.

Kimberly A. Foster, D. Thompson, Steve P. Wene, 2010, Journal of pharmaceutical sciences.